Guttman-McCabe Christopher 4
4 · Anterix Inc. · Filed Aug 8, 2024
Insider Transaction Report
Form 4
Anterix Inc.ATEX
Guttman-McCabe Christopher
Chief Reg & Comm Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-08-06+85,000→ 85,000 totalExercise: $33.56From: 2027-03-27Exp: 2034-08-06→ Common Stock (85,000 underlying)
Footnotes (2)
- [F1]On March 27, 2024, the Compensation Committee of the Board of Directors of the Issuer granted the Reporting Person the stock options, at a strike price of $33.56 per share based upon the closing price of the Issuer's common stock on the Nasdaq on such date. In accordance with Nasdaq Listing Rules, the granted stock options were subject to, and were not exercisable until, the Issuer's stockholders approved an authorization of minimum shares of common stock underlying such stock options to exercise the referenced award. On August 6, 2024, stockholders of the Issuer approved Amendment No. 1 to the Issuer's 2023 Stock Plan, which authorized an additional 1,100,000 shares under the Issuer's 2023 Stock Plan and satisfied the award conditions of the Reporting Person's stock option award.
- [F2]The option shares will vest and become exercisable by the Reporting Person, if he is employed by the Issuer, on March 27, 2027, unless exercisable sooner in accordance with the terms of the award agreement or any other applicable agreement, arrangement or policy of the Issuer.